XM does not provide services to residents of the United States of America.
B
B

BayerAG


News

FDA Accepts Supplemental NDA For Nubeqa® (darolutamide) for Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer

BRIEF-FDA Accepts Supplemental NDA For Nubeqa® (darolutamide) for Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer Nov 21 (Reuters) - U.S. FDA ACCEPTS SUPPLEMENTAL NDA FOR NUBEQA® (DAROLUTAMIDE) FOR TREATMENT OF PATIENTS WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER Source text: ID:nBw9g79LVa
B

AJ Bell, Frequentis AG, Sage Group

EUROPE RESEARCH ROUNDUP-AJ Bell, Frequentis AG, Sage Group Nov 21 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including AJ Bell, Frequentis AG and Sage Group on Thursday. HIGHLIGHTS * AJ Bell AJBA.L : Jefferies raises target price to 530p from 485p * Crest Nicholson Holdings Plc CRST.L : Berenberg cuts PT to 195p from 215p * Frequentis AG FQT.DE : Berenberg initiates coverage with buy rating; PT EUR 33 * Sage Group SGE.L : Jefferies rais
A
B
B
C
E
F
K
L
L
M
N
R
R
S
S
S
W
Z
A
I
J
S

Imperial Brands, Morgan Sindall, WH Smith

EUROPE RESEARCH ROUNDUP-Imperial Brands, Morgan Sindall, WH Smith Nov 20 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Imperial Brands, Morgan Sindall and WH Smith on Wednesday. HIGHLIGHTS * Ashtead Group Plc AHT.L : Panmure Liberum raises PT to 6900p from 6333p * Genuit Group Plc GENG.L : RBC cuts target price to 505p from 515p * Imperial Brands IMB.L : RBC raises target price to 2,100p from 2,000p * Morgan Sindall MGNS.L : Panmu
A
A
A
A
B
C
C
D
E
G
G
H
H
I
N
P
P
S
S
T
V
W
B
E
I
U

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Blackstone, Robinhood Markets, Adani Infra, AeroVironment Updates: Bakkt, Amcor Plc Nov 19 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1030 GMT on Tuesday: ** Blackstone BX.N has agreed to buy Jersey Mike's Subs, the sandwich chain said, in a deal that a source said valued the company at around $8 billion, including debt.
B

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Nov 19 (Reuters) - The following bids, mergers, acquisitions, and disposals were reported by 1030 GMT on Tuesday: ** U.S. activist investor Elliott Management has taken a 5.03% stake in Tokyo Gas 9531.T , a regulatory filing showed, as it seeks to push Japan's biggest city-gas provider to boost shareholder value.
B

Bayer acquires rights to Cytokinetics' heart drug in Japan

Bayer acquires rights to Cytokinetics' heart drug in Japan FRANKFURT, Nov 19 (Reuters) - Bayer BAYGn.DE on Tuesday struck a collaboration deal with U.S. biotech firm Cytokinetics CYTK.O to acquire certain rights in Japan to an experimental heart drug, as the German group strengthens its cardiovascular business with smaller deals. Cytokinetics will receive 50 million euros ($53 million) upfront, plus up to 90 million euros contingent on certain development achievements, Bayer said in a statement.
B

Bayer Strengthens Cardiovascular Portfolio With Cytokinetics' Aficamten In Japan

BRIEF-Bayer Strengthens Cardiovascular Portfolio With Cytokinetics' Aficamten In Japan Nov 19 (Reuters) - Bayer AG BAYGn.DE : STRENGTHENS CARDIOVASCULAR PORTFOLIO WITH CYTOKINETICS' AFICAMTEN IN JAPAN EXCLUSIVE LICENSE AGREEMENT WITH CYTOKINETICS TO DEVELOP AND COMMERCIALIZE AFICAMTEN IN JAPAN CYTOKINETICS WILL RECEIVE APPROXIMATELY EUR 70 MILLION
B

Allianz SE, Just Group, Zurich Insurance

EUROPE RESEARCH ROUNDUP-Allianz SE, Just Group, Zurich Insurance Nov 19 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Allianz SE, Just Group and Zurich Insurance Group, on Tuesday. HIGHLIGHTS * Allianz SE ALVG.DE : HSBC raises target price to EUR 350 from EUR 335 * Bayer AG BAYGn.DE : Berenberg cuts target price to EUR 22 from EUR 28 * Just Group JUSTJ.L : JP Morgan raises target price to 200p from 190p * Young & Co'S Brewery Plc
3
A
A
A
B
C
D
E
H
H
M
R
S
S
S
S
S
V
A
P
A
B
Z

4Imprint, Admiral Group, Prudential

EUROPE RESEARCH ROUNDUP-4Imprint, Admiral Group, Prudential Nov 18 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including 4Imprint, Admiral Group and Prudential, on Monday. HIGHLIGHTS * 4Imprint FOUR.L : HSBC cuts target price to 5830p from 6370p * Admiral Group Plc ADML.L : Barclays raises target price to 3326p from 3157p * Intermediate Capital Group Plc ICGIN.L : Citigroup raises PT to 2660p from 2610p * Prudential Plc PRU.L : Barclays
3
A
A
A
A
A
B
B
B
D
E
G
H
H
A
A
A
A
A
B
D
S

ASML Holding, Aviva, HSBC

EUROPE RESEARCH ROUNDUP-ASML Holding, Aviva, HSBC Nov 15 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including ASML Holding, Aviva, and HSBC on Friday. HIGHLIGHTS * ASML Holding NV ASML.AS : Jefferies raises target price to EUR 840 from EUR 760 * Aviva AV.L : HSBC raises to buy from hold * CVC Capital Partners Plc CVC.AS : Citigroup cuts to neutral from buy * HSBC HSBA.L : JP Morgan raises target price to 730p from 700p * Spirax Group SP
3
A
A
A
B
B
D
D
E
E
E
E
E
F
H
H
K
N
A
A
G
J

Bayer shareholders call on CEO to stem the tide of bad news

Bayer shareholders call on CEO to stem the tide of bad news Shareholders urge more decisive action after stock rout Shareholder Deka says restructuring programme needs to yield results CEO says management would work hard on way to 'bright future' By Ludwig Burger and Patricia Weiss FRANKFURT, Nov 15 (Reuters) - Some Bayer BAYGn.DE investors say CEO Bill Anderson should speed up turnaround efforts, including boosting efficiency and drug development, to restore confidence and revive the company's
B
B
C

Cash-strapped US farmers switch to generic crop chemicals, in blow to big manufacturers

Cash-strapped US farmers switch to generic crop chemicals, in blow to big manufacturers Switch to generics pressures brands like Bayer's Roundup Bayer shares dive to 20-year low Corteva and BASF may also face pressure By P.J. Huffstutter and Heather Schlitz Nov 14 (Reuters) - U.S. farmers struggling with slumping incomes and depressed grain prices have been switching to cheaper generic pesticides and fungicides as they plan for spring planting next year, which market analysts said could hit the
B
B
C

Babcock International, Scout24 Kymmene Oyj

EUROPE RESEARCH ROUNDUP- Babcock International, Scout24 SE, UPM-Kymmene Oyj Nov 14 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Babcock International, Scout24 SE and UPM-Kymmene Oyj, on Thursday. HIGHLIGHTS * Babcock International BAB.L : Jefferies raises target price to 750p from 720p * Just Eat Takeaway.Com JETJ.L : HSBC raises target price to 1575p from 1430p * Scout24 SE G24n.DE : Berenberg raises target price to EUR 110 fro
A
A
A
B
B
C
C
C
E
I
L
N
R
S
V
W
A
A
E
I
U

About 100 decongestant lawsuits claiming bogus ingredient tossed

About 100 decongestant lawsuits claiming bogus ingredient tossed By Diana Novak Jones Nov 13 (Reuters) - A New York federal judge on Tuesday dismissed about 100 lawsuits that claimed Procter & Gamble PG.N , Haleon HLN.L and other companies knowingly marketed and sold over-the-counter medications containing a decongestant that didn’t work. U.S. District Judge Brian Cogan in Brooklyn dismissed the lawsuits against medication manufacturers and grocery chains filed by consumers after a unanimous U
B
W

D.E. Shaw takes $108 million short bet on Bayer, regulatory filing shows

CORRECTED-UPDATE 1-D.E. Shaw takes $108 million short bet on Bayer, regulatory filing shows Corrects short amount in headline and first paragraph. Corrects the word "then" to "than" in paragraph 5 By Nell Mackenzie and Ludwig Burger LONDON/FRANKFURT, Nov 13 (Reuters) - Hedge fund D.E. Shaw took a 102 million euro ($108 million) short bet against Bayer BAYGn.DE on Tuesday, a regulatory filing in Germany showed, following an earnings presentation that sent its shares to a 20-year low, A short posi
B

D.E. Shaw takes $100 million short on Bayer, regulatory filing shows

CORRECTED-D.E. Shaw takes $100 million short on Bayer, regulatory filing shows Corrects amount to $108 million, not $1 billion LONDON, Nov 13 (Reuters) - Hedge fund D.E. Shaw took an 102 million euro ($108 million) short bet against BAYGn.DE Germany's Bayer on Tuesday following an earnings presentation that sent its shares to a 20-year low, a regulatory filing in Germany showed .
B

Cautious start for Europe after Tuesday's slide

LIVE MARKETS-Cautious start for Europe after Tuesday's slide STOXX 600 up 0.2% Energy sector leads Just Eat surges after unit sale U.S. futures edge down Nov 13 (Reuters) - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com CAUTIOUS START FOR EUROPE AFTER TUESDAY'S SLIDE Major European indexes are trading slightly higher on Wednesday with markets awaiting U.S.
B
E
F
S
U
G

Air Liquide, Evonik Industries, Sodexo

EUROPE RESEARCH ROUNDUP-Air Liquide, Evonik Industries, Sodexo Nov 13 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Air Liquide, Evonik Industries and Sodexo on Wednesday. HIGHLIGHTS * Air Liquide AIRP.PA : Jefferies raises to buy from underperform * Evonik Industries AG EVKn.DE : Jefferies cuts to underperform from hold * Ibstock IBST.L : Deutsche Bank raises to buy from hold * Sodexo EXHO.PA : Berenberg raises target price to E
A
B
B
B
B
C
D
E
E
G
K
S
S
U
A
B
B
S

India economic, corporate events on November 13

DIARY- India economic, corporate events on November 13 BENGALURU, Nov 13 (Reuters) - Diary of India economic, corporate events on November 13. ECONOMIC, CORPORATE .BSE500 EVENTS: RIC Local Start Date Local Time Indicator Name Period Reuters Poll Prior INM3MS=ECI 13 Nov 2024 17:00 M3 Money Supply 1 Nov, w/e 11.1% Start Date Strat Time RIC Company Name Event Name 13-Nov-2024 NTS ALKE.NS Alkem Laboratories Ltd Q2 2025 Alkem Laboratories Ltd Earnings Release 13-Nov-2024 NTS APLO.NS Apollo Tyres Ltd
A
B
S

China jitters, earnings drag Europe's STOXX 600 to three-month low

UPDATE 2-China jitters, earnings drag Europe's STOXX 600 to three-month low For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Basic resources lead sectoral losses Trump and coalition collapse dent German investor morale Bayer sinks on 2025 earnings fall forecast UK's Convatec Group shares jump after FY24 guidance raise STOXX 600 down 2% Updated with closing levels By Shashwat Chauhan and Pranav Kashyap Nov 12 (Reuters) - Europe's main inde
A
B
B
C
I
M
T
E
F
U
G



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.